A detailed history of Providence Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 36,409 shares of JNJ stock, worth $5.32 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
36,409
Previous 3,093 1077.14%
Holding current value
$5.32 Million
Previous $481,000 1097.3%
% of portfolio
1.3%
Previous 0.13%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $5.17 Million - $5.42 Million
33,316 Added 1077.14%
36,409 $5.76 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $6,541 - $7,328
42 Added 1.38%
3,093 $481,000
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $4.26 Million - $4.58 Million
-27,600 Reduced 90.05%
3,051 $505,000
Q1 2023

May 17, 2023

SELL
$151.05 - $180.26 $713 Million - $851 Million
-4,720,305 Reduced 99.35%
30,651 $4.75 Million
Q1 2023

May 17, 2023

BUY
$151.05 - $180.26 $709 Million - $846 Million
4,694,856 Added 8368.73%
4,750,956 $736 Million
Q1 2023

May 10, 2023

BUY
$151.05 - $180.26 $7.97 Million - $9.51 Million
52,756 Added 1577.63%
56,100 $8.7 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $4 Million - $4.48 Million
-24,943 Reduced 88.18%
3,344 $590,000
Q3 2022

Nov 09, 2022

BUY
$161.33 - $179.52 $4.04 Million - $4.49 Million
25,020 Added 765.84%
28,287 $4.62 Million
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $28,592 - $31,621
-170 Reduced 4.95%
3,267 $580,000
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $6,641 - $7,542
42 Added 1.24%
3,437 $609,000
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $28,223 - $31,314
-181 Reduced 5.06%
3,395 $581,000
Q3 2021

Nov 09, 2021

BUY
$161.5 - $179.47 $48,934 - $54,379
303 Added 9.26%
3,576 $578,000
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $96,485 - $103,497
605 Added 22.68%
3,273 $539,000
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $36,889 - $41,085
241 Added 9.93%
2,668 $438,000
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $16,590 - $19,042
-121 Reduced 4.75%
2,427 $382,000
Q2 2020

Aug 04, 2020

SELL
$128.81 - $155.51 $44,954 - $54,272
-349 Reduced 12.05%
2,548 $358,000
Q1 2020

May 12, 2020

BUY
$111.14 - $153.99 $9,558 - $13,243
86 Added 3.06%
2,897 $380,000
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $74,077 - $85,081
581 Added 26.05%
2,811 $410,000
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $21,246 - $23,366
-162 Reduced 6.77%
2,230 $311,000
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $23,886 - $26,560
-190 Reduced 7.36%
2,392 $334,000
Q4 2018

Feb 01, 2019

SELL
$122.84 - $147.84 $20,268 - $24,393
-165 Reduced 6.01%
2,582 $333,000
Q3 2018

Nov 08, 2018

SELL
$121.58 - $142.88 $36,474 - $42,864
-300 Reduced 9.85%
2,747 $380,000
Q2 2018

Aug 08, 2018

SELL
$119.4 - $131.76 $50,745 - $55,997
-425 Reduced 12.24%
3,047 $370,000
Q1 2018

May 10, 2018

SELL
$125.1 - $148.14 $15,637 - $18,517
-125 Reduced 3.48%
3,472 $445,000
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $471,998 - $516,601
3,597
3,597 $503,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Providence Capital Advisors, LLC Portfolio

Follow Providence Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.